University of Adelaide warns doctors against Melatonin

The University of Adelaide has warned doctors against using Melatonin, as they believe its safety has not been thoroughly tested.

Melatonin is a hormone in the body that is produced with the onset of darkness and plays a key role in fine tuning people’s circadian rhythms, including the timing of sleep and other biological processes. 

In a paper released in the journal of Pediatrics and Child Health, professor David Kennaway, head of the Circadian Physiology Laboratory at the University of Adelaide’s Robinson Research Institute. 

This will warn that offering melatonin supplements to children may lead to severe side effects when children reach an older age.

Professor Kennaway said: “The use of melatonin as a drug for the treatment of sleep disorders for children is increasing and this is rather alarming. It's considered to be a 'dietary supplement', not a regulated drug, and is therefore readily available.”

He added that melatonin is registered as a treatment for primary insomnia in those aged 55 years or above. 

Posted by Edward Bartel

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Healthcare

© Spire Healthcare Group plc (2016)